Patents Represented by Law Firm Fulbright & Jaworwski
  • Hybridomas producing antibodies specific for lyme disease antigens OspA and OspB
    Patent number: 5856447
    Abstract: The present invention provides a vaccine against Lyme disease, wherein it contains one or more monoclonal antibodies which are specific for the 31 kD antigen (OspA) or the 34 kD antigen (OspB) of Borrelia burgdorferi.The present invention also provides a process for obtaining this vaccine, as well as new monoclonal antibodies, hybridomas and antigens.
    Type: Grant
    Filed: February 23, 1998
    Date of Patent: January 5, 1999
    Assignee: Max-Planck-Gesellschaft zur Forderung der Wissenschaften
    Inventors: Markus M. Simon, Ulrich E. Schaible, Klaus Eichmann, Michael Kramer, Wallich Reinhard